In hemodialysis patients with type 2 DM, diabetes duration and serum glycated albumin, a marker of glycemic control in patients receiving hemodialysis11,12, were 22.9 ± 12.8 years, and 20.1 ± 4.73%, respectively. The gene discussed is ALB; the disease is diabetes mellitus.